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Medical Sciences
AUTOLOGOUS PLATELET GEL: A NOVEL TREATMENT FOR MYOCARDIAL
INFARCTIONS (HEART ATTACK). C. W . Gurnee1 ,2 , B.Y. Hargrave 1,2 , S.J. Beebe.1
& X. Shu1 , 1 Frank Reidy Research Center for Bioelectrics, Norfolk VA 23510 and 2 Old
Dominion University, Norfolk VA 23529. Autologous Platelet Rich Leukocyte Plasma
(PRLP) or “platelet gel” as it is sometimes called is a platelet/leukocyte rich
concentrate made from the whole blood of a patient. PRLP, when applied to soft tissue
wounds, enhances healing by placing a high concentration of growth factors (released
from platelets activated by a known platelet activator) at the site of damage. W e
examined PRLP in the rabbit heart after Acute Myocardial Infarction (AMI) and
reperfusion and tested its ability to support and/or improve mechanical left ventricular
function. In Vitro study: In the rabbit Langendorff heart treated with PRLP (injected
into the myocardium of the left ventricle) and exposed to global ischemia there was a
shift in systolic and diastolic pressure curves suggesting less systolic and diastolic
dysfunction compared to the saline treated controls. The PRLP treated but not the saline
treated hearts were capable of increasing left ventricular work function to a level above
baseline after 40 min of reperfusion. In Vivo study: Fourteen days after an AM I, the
rabbit heart treated with PRLP (injected into the myocardium of the left ventricle) at
the time of the infarct was stressed with dobutamine and was capable of increasing left
ventricular positive dP/dt and decreasing negative dP/dt compared to the saline treated
heart. PRLP supports mechanical left ventricular function in the rabbit heart following
AMI. These preliminary data suggest that PRLP, injected into the myocardium may
function to regulate left ventricular pressures and improve function following AMI.
GENE EXPRESSION OF SACCHAROMYCES CEREVISIAE EXPOSED TO
COMMERCIAL W OOD PRESERVATIVES BY DNA MICROARRAY ANALYSIS
AND RT-PCR. Madison M . Stevens & Consuelo J. Alvarez, Dept. of Biol. and
Environ. Sciences, Longwood Univ., Farmville VA 23909.
Creosote and
pentachlorophenol (PtCP) are commercial wood preservatives regulated by the EPA
because of their toxicity to wildlife and their possible role as human carcinogens. This
baker’s yeast was used as a model system to observe changes in gene expression after
exposure to these compounds. Cells were exposed to a creosote concentration of
50ng/ml and to a PtCP concentration of 50ìM. A total of 20 DNA microarray chips
were tested (7 creosote chips, 7 PtCP chips, and 6 solvent chips (used as controls)). 27
genes from creosote and 180 genes from PtCP were found to have significant changes
in expression and among them, 15 genes’ RNAs were chosen for reverse transcription
and RT-PCR to validate their change in expression. In both experimental treatments,
genes with roles in cell cycle regulation, drug transport, and response to stress had
significant changes in expression. Clustering analysis revealed highly correlated gene
expression in genes associated with mitotic controls. Because creosote and PtCP have
been indirectly linked to causing cancer in humans, BLASTn and BLASTp analysis on
the National Center for Biotechnology Information (NCBI) website was used and
confirmed that some genes with significant changes in expression had homology to
human genes and protein sequences. Overall, the results of this study are a sign of the
necessity for more studies to be done by the EPA and workers’ health associations in

Virginia Journal of Science, Vol. 60, No. 2, 2009

https://digitalcommons.odu.edu/vjs/vol60/iss2

92

VIRGINIA JOURNAL OF SCIENCE

order to establish job/health regulations and it could be a starting point for R-1
institutions that concentrate their research in cancer studies.
MBD2 REGULATED CANDIDATE GENES FOR MODULATION OF HUMAN
GAMMA GLOBIN GENE EXPRESSION IN ADULT ERYTHROID CELLS. Merlin
N. Gnanapragasam1 , Jeremy W . Rupon, Shou Zhen W ang 4 , Latasha C. Redmond 1 ,
Omar Y. Mian3 , Catherine I. Dumur, C.I.5 , Kelly J. Archer5 , Joyce A. Lloyd 1 & Gordon
D. Ginder1 ,2 ,4 Departments of 1 Human and Molecular Genetics, 2 Internal Medicine,
3
Microbiology and Immunology, 5 Pathology, 5 Biostatistics, 4 Massey Cancer Center,
Virginia Commonwealth University, Richmond, VA 23298. Reexpression of the
silenced fetal ã -globin gene in adult erythrocytes of individuals with â-globin disorders
such as sickle cell anemia and â-thalassemia, is of therapeutic interest due to its
ameliorating effects1 -5 . W e have previously shown that knock out of methyl CpG
binding domain protein 2 (MBD2) in transgenic mice carrying the human beta globin
gene cluster (â-YAC mice), results in de-repression of ã globin gene expression in adult
erythrocytes. However, MBD2 does not directly bind to the ã-globin gene to mediate
its silencing. W e hypothesize that MBD2 may suppress human ã globin gene
transcription in adult erythrocytes by an indirect mechanism ie., by binding to and
repressing transcription of intermediary gene/s which may be involved in ã globin gene
regulation. Microarray assays were performed on Affymetrix GeneChip® 430A 2.0
array for protein coding genes using RNA from four MBD2-/- and wild type mice adult
erythroid cells. Growth factor receptor bound protein 2-associated protein1 (GAB1) and
Zinc finger and BTB domain containing 32 (ZBTB32) were identified as priority
candidate genes. Functional studies indicate that overexpression of these validated
candidate genes can cause reexpression of ã-globin gene in Chemical Inducer of
Dimerization dependent â-YAC mouse adult bone marrow cells.
T H E PREV EN T IO N O F EPILEPT O G EN ESIS T HRO UGH CALCIU M
MODULATION IN A HIPPOCAMPAL NEURONAL CULTURE M ODEL OF
STATUS EPILEPTICUS-INDUCED ACQUIRED EPILEPSY. Nisha Nagarkatti,
Laxmikant S. Deshpande & Robert J. DeLorenzo, Dept. of Neurology, VA
Commonwealth Univ, Richmond VA 23298. Currently, no treatment exists to prevent
the development of acquired epilepsy (AE) following injury such as status epilepticus
(SE). In this study, the ability of a new drug, carisbamate, to prevent the development
of spontaneous recurrent epileptiform discharges (SREDs) and alter intra-neuronal Ca 2+
levels ([Ca2 + ] i ) following in vitro SE was evaluated. After treatment in low-Mg 2+
containing solution to mimic SE, neuronal cultures developed SREDs (in vitro AE).
Cultures were treated, post-SE, with carisbamate (200 ìM) for 12 h. The drug was then
washed out of the system and neurons were evaluated for the expression of SREDs 24
h post-washout. Drug-treated neurons failed to display SREDs, in contrast to the
controls. The ability of carisbamate to block elevations in [Ca2 + ] i after SE was also
tested because alterations in Ca2 + dynamics and homeostatic mechanisms have been
associated with plasticity changes and ultimately, the development of epilepsy.
Following SE, sustained elevations in [Ca2 + ] i were observed and carisbamate was able
to lower [Ca2+ ] i when administered post-SE. W hen evaluated for the ability to restore
Ca2 + homeostasis following glutamate challenge, the drug-treated neurons showed
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enhanced recovery. This study suggested that carisbamate is able to prevent the
development of SREDs in vitro; furthermore, the ability of carisbamate to alter Ca 2+
dynamics may contribute to its anti-epileptogenic properties. Supported by: NIH grants
RO1NS051505, RO1NS052529, UO1NS058213 and AHA Pre-doctoral fellowship.

MODELING PHYSICAL ACTIVITY IN W ORKING ADULTS: HOW SUITABLE
IS THE EXPANDED PARALLEL PROCESS MODEL?. A. B-H-Sam 1 , M. L.
W alker 2 , S. Plichta 1 , and G. Maihafer 2 ; 1 School of Community and Environmental
Health, College of Health Sciences, Old Dominion University and 2 School of Physical
Therapy, College of Health Sciences, Old Dominion University. The usefulness of the
Expanded Parallel Process Model in predicting health enhancing physical activity is
assessed in the context of risk for coronary heart disease. The study involves secondary
analyses of a dataset from a group of working adults who elected first to participate in
a health plan ‘Quality Improvement Study’ and were then randomly selected to receive
an intervention program designed to increase activity. Data on self-reported
demographics, physical activity levels, health status characteristics and perceptions
measured on a Likert-type scale known as the Risk Behavior Diagnosis Scale are
analyzed. The Risk Behavior Diagnosis Scale measures represent the model
hypothesized mediating variables which are perceived severity, perceived
susceptibility, perceived response efficacy and perceived self-efficacy. Results of data
analyses offer limited and weak support for use of the Expanded Parallel Process Model
to explain differences in health enhancing physical activity behavior of working adults.
The magnitude of the hypothesized Expanded Parallel Process Model mediator
variables observed in the study, though small, may suffice as a call for further research
using a different research approach (longitudinal). Health behavior is complex, and the
most important determining factors of physical activity may also not have been
included in the analysis. A different theoretical model, in this case, may help to explain
physical activity behavior.
PATTERNS OF ETHANOL-RESPONSIVE GENE EXPRESSION IN FYN KINASE
KNOCKOUT MICE. Sean P. Farris & Michael F. Miles, Dept. of Pharmacology &
Toxicology, Virginia Commonwealth University, Richmond, VA 23298. The molecular
mechanisms underlying alcoholism are largely unknown, however, changes in gene
expression are proposed as critical molecular adaptations leading to the development
lasting ethanol related phenotypes. Two inbred mouse strains with divergent ethanol
related behaviors, DBA/2J (D2) and C57BL/6J (B6), also exhibit differing basal and
acute ethanol-responsive gene expression patterns among discrete brain regions
including prefrontal cortex (PFC). Bioinformatic analysis of D2 and B6 microarray
studies implicated Fyn kinase as a potential mechanism regulating ethanol-responsive
myelin gene expression. Fyn knockout (KO) mice have abnormal CNS myelination and
are more sensitive to ethanol related behaviors. Using DNA microarrays we assayed
Fyn KO mouse PFC to identify downstream basal and acute ethanol-responsive gene
expression patterns. Characterizing the associated gene networks will test the
hypothesis that Fyn is required for acute ethanol regulation of myelin gene networks,
and identify novel Fyn related signaling mechanisms. Microarray analysis revealed 565
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genes altered by genotype, and 746 genes altered by ethanol (P<0.001). Several genes
with a functional relationship to myelin including progesterone receptor (Pgr) were
regulated by ethanol in Fyn KO PFC, suggesting a novel relationship may exist
between Fyn and Pgr in regulating ethanol-responsive myelin gene expression.
Continued investigation of this functional relationship and associated gene networks
may aid in the future development of more successful pharmacotherapies for
alcoholism and related CNS myelin toxicity.
NANOSECOND PULSED ELECTRIC FIELDS INDUCE APOPTOTIC-LIKE CELL
DEATH IN MURINE E4 SQUAMOUS CARCINOMA CELLS BY MULTIPLE
MECHANISMS. W ei Ren & Stephen J. Beebe, Frank Reidy Research Center for
Bioelectrics, Old Dominion University, Norfolk VA 23510. Nanosecond pulsed electric
fields (nsPEFs) are pulses with ultra-short duration (ns), high power (mega watts), but
low energy density (mJ/cc), which are distinctly different from conventionalelectroporation pulses. NsPEFs have emerged as a novel method to modulate
intracellular structures and functions. To determine the signaling pathways in nsPEFinduced cell death, murine E4 squamous carcinoma cells were exposed to multiple
pulses from 0 to 60kV/cm with 300ns duration. Cell death occurred with decreases in
the mitochondria membrane potential, the appearance of active caspases, and the
release of cytochrome c from the mitochondria into the cytoplasm. Using a cell
permeable, irreversible inhibitor, the appearance of active caspases was observed
within1 hour post pulse. At lower electric fields, active caspases appeared in the
apparent absence of cytochrome c release. However, at higher electric fields
cytochrome c release was observed. Using irreversible inhibitors of active caspases,
active caspase-8, caspase-9 as well as caspase 3/7 were seen within 2 hours post pulse
in an electric-field dependent manner. In addition, inhibition of caspase activity using
z-VAD-fmk partially attenuated cytochrome c release. These results suggest that
nsPEFs induce an apoptotic-like cell death as indicated by using both mitochondriadependent and –independent mechanisms in E4 cells.

METHYL BINDING DOMAIN PROTIEN 2 (MBD2) MAINTAINS TUMOR
SUPPRESSOR SILENCING AND PROM OTES EPITHELIAL
DEDIFFERENTIATION IN BREAST CANCER. O.Y. Mian, M. N. Gnanapragasam,
S. Z. W ang & G. D. Ginder, Massey Cancer Center, Richmond, VA 23298. MethylCpG Binding Proteins (MCBPs) function as interpreters of epigenetic signals encoded
in the genome. W e study the function of Methyl-Binding Domain Proteins (MBDs) in
human mammary epithelial cancers, where repatterning of CpG methylation is
common. W e find Methyl Binding Domain Protein 2 (MBD2) promotes abnormal
multi-cellular morphology of tumor cells grown in extracellular matrix extracts. Stable
MBD2 knockdown in MCF7 cells leads to an increased proportion of differentiated
epithelial structures (e.g. acinii, 70%, [CI=0.55-0.83]) when compared with
untransfected (46%, [CI=0.39-0.53], p#0.038) and scrambled shRNA transfected (37%,
[CI=0.29-0.45], p#0.012) control cells. To identify the genes underlying this M BD2
dependant phenotype, high throughput quantitative PCR data were probed using self
organizing map (SOM) analysis. W e found a small subset of the breast cancer specific

Virginia Journal of Science, Vol. 60, No. 2, 2009

https://digitalcommons.odu.edu/vjs/vol60/iss2

ABSTRACTS

95

tumor suppressors known to be silenced by promoter hypermethylation were regulated
by MBD2 (n=7, 15%). The M BD2 dependant genes were rapidly re-suppressed upon
rescue with a shRNA binding site variant MBD2 and ChIP studies confirmed binding
of M BD2 at genes within the MBD2 dependant cluster. W e demonstrate MBD2
maintains aberrant dedifferentiation in breast cancer through a network of
epigenetically inactivated tumor suppressor genes. Based on these findings, we
intimate a pathologic role for M BD2 in the initiation and progression of human
mammary epithelial neoplasia. This work was supported by NIH-2R01DK02990226A2

NEUTROPHIL INFILTRATION AND RELEASE OF REACTIVE OXYGEN
SPECIES ENHANCE VASCULAR REACTIVITY TO ANGIOTENSIN II VIA THE
RhoA KINASE PATHW AY.
Nikita Mishra, MD, Scott W alsh, PhD,
OB/GYN/Physiology, VCU, Richmond,VA 23298. W omen with preeclampsia have
enhanced vascular reactivity to Angiotensin II (Ang II). W e hypothesized that
neutrophil release of ROS enhances vessel reactivity to Ang II by activating the RhoA
kinase pathway. Resistance arteries from omental fat biopsies of normal pregnant
patients undergoing C-sections (n=20) were studied. Ang II dose response (10 -9 M to
10-5 M) was done. The Ang II dose response was repeated with neutrophils (2000/mm 3 )
in the vessel lumen. Ang II + neutrophils was repeated with addition of superoxide
dismutase (150 U/ml)/catalase (5000 U/ml) to quench ROS or with addition of Y27632 (3ìM), a specific Rho A kinase inhibitor. Ang II dose response was also tested
with ROS generating solution (hypoxanthine, 0.36mM + xanthine oxidase, 0.004
IU/ml), Ang II + ROS + SOD/catalase or Ang II + ROS + Y-27632 (3ìM ). Ang II
caused a dose response contraction with maximum response at 10 -6 M (Change in
diameter of -18.6 ± 2.0m, mean ± S.E). W ith activated neutrophils, vasoconstrictive
response to Ang II was significantly greater at 10 -9 M, 10 -7 M, 10 -6 M and 10 -5 M (-44.5
± 5.9m, p<0.01). SOD/catalase and Y-27632 significantly blocked the enhanced
response to Ang II by activated neutrophils. Similar results were observed with ROS.
These results suggest that neutrophil infiltration in systemic vasculature of preeclamptic
women explain the enhanced reactivity to Ang II in preeclampsia. HL069851.
POSITIVE ALLOSTERIC MODULATION OF á4â2 NEURONAL nAChRs BY
DESFORMYLFLUSTRA-BROM INE AND ITS ANALOGS. N. A. German1 , J.-S.
Kim1 , A. Pandya2 , M. Schulte2 & R. A. Glennon1 , 1 Department of Medicinal Chemistry,
Virginia Commonwealth University, Richmond VA 23298 and 2 Department of
Chemistry and Biochemistry, University of Alaska, Fairbanks AK 99775. Neuronal
nicotinic acetylcholine receptors (nAChRs) appear to play an important role in
cognitive and attentive processes. An alteration in expression or function of á4â2
nAChRs also has been associated with neurodegenerative disorders and in certain
aspects of drug abuse. Positive allosteric modulators (PAMs) have been envisioned as
a potential therapeutic treatment; however there is a very limited number of
compounds, if any, that have shown selective allosteric modulation of á4â2 nAChRs.
A novel indole alkaloid desformylflustrabromine (dFBr), recently isolated from a
marine species, has been shown to selectively modulate á4â2 nAChRs through an
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allosteric mechanism. The present investigation was designed to determine structural
features important for the actions of dFBr. Proposed compounds were prepared using
several synthetic schemes. Biological activities of synthesized compounds were
evaluated using two-electrode voltage clamp techniques employing Xenopus laevis
oocytes injected with cDNAs of the human á4â2 receptor. As a result of this study
dFBr and its synthetic analogs were shown to be positive allosteric modulators of á4â2
nAChRs and key structural features were identified for this action. [Supported, in part,
by a Virginia Center on Aging grant and a VCU Department of Pharmacology and
Toxicology Training Grant (T32 DA007027-34).]
THE EFFECT OF SUCRALOSE ON OBESITY AND DIABETES PROGRESSION
IN A TYPE II DIABETES MODEL, THE TALLYHO/JNGJ M OUSE. Matthew C.
Johnson & Dianne M. Baker, Dept. of Bio. Sci., Univ. M ary W ashington,
Fredericksburg, VA 22401. The high incidence of type II diabetes is one of the most
pressing medical concerns in the United States. Treatment of type II diabetes
commonly includes management of blood glucose and body weight through diet and
exercise. To regulate blood glucose, type II diabetics often replace dietary sugars with
artificial sweeteners such as sucralose (Splenda®). W hile sucralose is typically
considered to be a safe replacement for sugar, some recent studies have found adverse
effects on glucose balance and food consumption. In this study, we tested the effects
of sucralose on the progression of type II diabetes in mice. W e hypothesized that the
presence of sucralose in the diet of type II diabetic mice would accelerate the
progression of the disease, resulting in increased glucose levels compared to diabetic
control animals. Secondly, we hypothesized that sucralose in the diet would increase
food consumption and therefore increase body mass in type II diabetic mice compared
to control-fed type II diabetic animals. To test these hypotheses, we measured food
intake, body mass, and blood glucose levels (both fasting and glucose tolerance test
levels) in sucralose-fed and control-fed animals over a 10 week treatment period.
Plasma samples were also collected over this same period for measurement of insulin
and triglyceride levels. Contrary to expectations, sucralose-fed mice had lower blood
glucose and triglyceride levels than control-fed mice. Additionally, we found no
significant effect of sucralose on insulin concentration, food intake or body mass. These
results suggest that sucralose may slow the progression of type II diabetes.
T H E E FFE C T S O F Ä 9 -T ET RAH Y D R O C A N N IB IN O L, T H E M A JO R
PSYCHOACTIVE COMPONENT OF MARIJUANA, ON FOOD AND BRAIN
REW ARD. M. A. Rolfes1 ,2 , A. J. Kwilasz2 , L. S. Harris2 , R. E. Vann 1 , 2 , Departments
of 1 Psychology, & 2 Pharmacology/Toxicology, VCU, Richmond, VA, 23298. Previous
studies in rats using progressive ratio (PR) schedules of reinforcement have suggested
a role for cannabinoid receptor 1 (CB1) agonists in both food consumption and feeding
motivation. PR procedures that assess motivation commonly use food reinforcement,
however these procedures are unable to delineate whether motivation to respond is an
enhancement of feeding or reward mechanisms. Intracranial self-stimulation (ICSS),
a procedure in which animals are trained to respond for stimulation of the medial
forebrain bundle, is well suited to investigate motivation to respond for reward.
Accordingly, the CB1 agonist, Ä9 -tetrahydrocannabinol (THC), was assessed for its
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ability to alter motivation to respond for food or brain stimulation reward (BSR). ICR
mice were trained to respond for food or BSR (158 Hz, 150 µA) on a PR2 schedule of
reinforcement, in which the response requirement increased by 2 lever presses after
every 4 reinforcers earned. Breakpoints were assessed daily to measure motivation to
respond for reinforcement and tests with vehicle and THC (1, 3, 10, and 17.1 mg/kg)
were conducted. THC administration significantly increased breakpoints for food and
BSR; however, breakpoint increases for BSR were observed at a higher dose than for
food. Operant response rates were unaffected by THC. These results add to a growing
body of literature that suggests an enhancing role for CB1 agonists in feeding and
reward motivated behavior in mice.
THE DOMESTIC FOW L (GALLUS) AS A MODEL OF OBESITY AND SEX
SPECIFICITY IN THE METABOLIC SYNDROME. R.P. W yeth 1 , A. Santo 1 , K.E.
Harris2 , T.V. Palacios1 , R.M. Lewis3 , C.F. Honaker3 & P.B. Siegel3 , 1 Edward Via,
Virginia College of Osteopathic Medicine, 2 Dept. of Human Nutrition, Foods and
Exercise, 3 Dept. of Animal and Poultry Sciences, Virginia Polytechnic Institute and
State University, Blacksburg. High body fat content is associated with increased
morbidity and mortality. The prevalence of overweight or obese humans grows with
alarming rapidity. Globally 1.7 billion people are overweight or obese producing a
pandemic of cardiovascular disease (CVD). Principal risks for CVD include abdominal
obesity, hyperlipidemia, dyslipidemia, hyperglycemia, insulin resistance, and
hypertension, known collectively as the metabolic syndrome. The ability to define
mechanisms that interact to produce the metabolic syndrome in humans is limited by
lack of a single mammalian model that fulfills all criteria for this syndrome. W e
propose a suitable alternative. A line of chickens developed at Virginia Tech was
selected for high juvenile body weight that not only exhibits rapid juvenile growth but
also becomes morbidly obese unless feed restricted. Thus, these high weight chickens
provide an attractive model for studying CVD associated with the metabolic syndrome.
Based on the metabolic characteristics and preliminary data on these high weight
chickens, by inducing obesity, we produced a sexually differentiating effect in the a 1
adrenergic response of this proposed non-mammalian model of the metabolic
syndrome. This study was funded by a grant from the Harvey Peters Foundation.
THE FLAVONOID LUTEOLIN INCREASES VASODILATATION THROUGH
NON-GENOMIC NITRIC OXIDE RELEASE. Hongwei Si1 , Dongmin Liu 1 & Richard
P. W yeth2 , 1 Laboratory of Molecular Nutrition, Department of Human Nutrition, Foods
and Exercise, College of Agriculture and Life Sciences, Virginia Polytechnic Institute
and State University, Blacksburg, Virginia, 2 Divisions of Anatomy and Physiology,
Edward Via Virginia College of Osteopathic Medicine, Blacksburg, Virginia. Luteolin
is a plant flavonoid and vasodilator. W e tested if luteolin will stimulate endothelial NO
synthase (eNOS) phosphorylation and decrease alpha 1 adrenergic (a 1 AR) contraction,
in cultured human aortic endothelial cells (HAECs) and isolated rat aorta. W hen intact
rat aortic rings were constricted with the specific a 1AR agonist phenylephrine,
followed by cumulative addition of luteolin, a dose dependent relaxation was produced.
In rings pretreated with the eNOS inhibitor, N-nitro-L-arginine methyl ester,
luteolin–induced vasorelaxation was partially blocked. W hen HAECs were incubated
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with luteolin, luteolin phosphorylated eNOS and stimulated NO release. These data
indicate that, within arterial vasculature, luteolin: 1) induces vasorelaxation through an
endothelium dependent mechanism; 2) produces a dose dependent and immediate
decrease in a 1 AR induced contraction; 3) increases the phosphorylation of eNOS and
subsequently improves NO production. Taken together, we suggest that luteolin
induces vasorelaxation not by increased eNOS translation but rather by receptormediated stimulation of NO production by extant eNOS.

Natural History & Biodiversity
SMALL MAMMALS FROM THE CLOUD FOREST AT CERRO BOBI, SIERRA
DE LOS CUCHUMATANES,GUATEMALA. Nicte Ordonez 1 , W alter Bulmer 2 , Ralph
P. Eckerlin2 , & John O. Matson3 , 1 Dept. Biol. Sci., Texas Tech Univ., Lubbock, TX
79409, 2 Div. of Nat. Sci., Northern VA Community Coll., Annandale, VA 22003,
3
Dept. Biol. Sci., San Jose State Univ., San Jose, CA 95192. Very little is known about
small mammal ecology and distribution in the highlands of Guatemala. Small mammals
were removal trapped from the mixed hardwood/coniferous cloud forest at Cerro Bobi
in the Sierra de los Cuchumatanes, Huehuetenango, Guatemala during July 2005 and
December 2005/January 2006.The coniferous cloud forest is located at 5km SW San
Mateo Ixtatan, NW side of Cerro Bobi (3110m).The habitat can be characterized as
follows: overstory of fir (Abies), pines (Pinus), oaks (Quercus), and other broad-leaved
trees. A heavy litter of moss, lycopsids, ferns, and fallen logs was on forest floor. A
total of 131 individuals representing 10 species of small mammals (8 rodent and 2
shrew) was collected. The site was sampled during two distinct seasons (wet and dry).
W hile there were small differences in the small mammal species composition and
abundance between the 2 samples, this was attributed to small sample size and
sampling error. Peromyscus guatemalensis was the most abundant species in both
seasons. Especially important is the collection of the Maya mouse (Peromyscus
mayensis), not formally reported since its original description in 1975.
IDENTIFICATION OF CRYPTIC CHLOROPHYTES THROUGH MOLECULAR
SEQUENCE DATA. Matthew R. Semcheski, Todd A. Egerton & Harold G. Marshall,
Department of Biological Sciences, Old Dominion University, Norfolk VA 23529. The
phenomenon of phenotypic plasticity is evident in many organisms throughout the
natural world and is a byproduct of the biotic and abiotic factors of the environment in
which an individual or population inhabits. Plasticity is especially prominent among
microscopic photosynthetic taxa, which produce a variety of ambiguous forms. W e
identified a number of morphologically variable specimens, all originating from a
single monoculture of the chlorophyte Scenedesmus sp., which included single-cell
spinous and non-spinous forms, along with mulitcelluar spinous and non-spinous
forms. In order to discern plasticity vs. genetic variation in a number of ecomorphs of
Scenedesmus sp., the complete ITS-1, 5.8S, and ITS-2 region was sequenced.
Phylogenetic analyses confirmed that all samples analyzed, while being
morphologically distinct, do indeed belong to the Scenedesmus genus. Upon further
investigation, it was determined that at the outset, with nutrients non-limiting and an
absence of predators, Scenedesmus sp. grew rapidly in the single-cell non-spinous form.
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